| __timestamp | AstraZeneca PLC | Walgreens Boots Alliance, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 5842000000 | 54823000000 |
| Thursday, January 1, 2015 | 4646000000 | 76691000000 |
| Friday, January 1, 2016 | 4126000000 | 87477000000 |
| Sunday, January 1, 2017 | 4318000000 | 89052000000 |
| Monday, January 1, 2018 | 4936000000 | 100745000000 |
| Tuesday, January 1, 2019 | 4921000000 | 91915000000 |
| Wednesday, January 1, 2020 | 5299000000 | 95905000000 |
| Friday, January 1, 2021 | 12437000000 | 104442000000 |
| Saturday, January 1, 2022 | 12391000000 | 104437000000 |
| Sunday, January 1, 2023 | 8040000000 | 112009000000 |
| Monday, January 1, 2024 | 10207000000 | 121134000000 |
In pursuit of knowledge
In the ever-evolving landscape of global business, understanding the cost of revenue is crucial for evaluating a company's financial health. This comparison between AstraZeneca PLC and Walgreens Boots Alliance, Inc. from 2014 to 2023 offers intriguing insights.
AstraZeneca, a pharmaceutical giant, saw its cost of revenue fluctuate, peaking in 2021 at approximately 12.4 billion, a significant increase from 2014. However, by 2023, it had decreased to around 8 billion, indicating a strategic shift or operational efficiency.
In contrast, Walgreens Boots Alliance, a leader in retail pharmacy, consistently reported higher costs, with a notable rise from 54.8 billion in 2014 to an impressive 112 billion in 2023. This steady increase reflects its expansive retail operations and market dominance.
The data for 2024 is incomplete for AstraZeneca, highlighting the dynamic nature of financial reporting and the need for continuous analysis.
Eli Lilly and Company vs Walgreens Boots Alliance, Inc.: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down AstraZeneca PLC and Regeneron Pharmaceuticals, Inc.'s Expenses
AstraZeneca PLC vs Insmed Incorporated: Efficiency in Cost of Revenue Explored
AstraZeneca PLC vs BioMarin Pharmaceutical Inc.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: AstraZeneca PLC and Galapagos NV
Teva Pharmaceutical Industries Limited vs Walgreens Boots Alliance, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for Walgreens Boots Alliance, Inc. and Veracyte, Inc.
Cost of Revenue: Key Insights for Walgreens Boots Alliance, Inc. and HUTCHMED (China) Limited
Cost of Revenue Comparison: Walgreens Boots Alliance, Inc. vs Dyne Therapeutics, Inc.
Cost of Revenue Comparison: Walgreens Boots Alliance, Inc. vs Viridian Therapeutics, Inc.